Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic

• DOI: 10.1016/j.jstrokecerebrovasdis.2021.106231
• Publication Date: 2021-11-22T05:33:55Z
• Authors: Rahul Kulkarni; Shripad S Pujari; Dulari Gupta; Pawan Ojha; Megha Dhamne; Vyankatesh Bolegave; Pramod Dhonde; Anand Soni; Sikandar Adwani; Anand Diwan; Dhananjay Duberkar; Dhruv Batra; Rushikesh Deshpande; Kaustubh Aurangab...; Nilesh Palasdeokar
• Keywords: Adult; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Incidence; COVID-19; India; Middle Aged; Article; 3. Good health; Stroke; Cerebrovascular Disorders; 03 medical and health sciences; COVID-19 Testing; 0302 clinical medicine; Humans; Mucormycosis; Female; Pandemics; Aged; Retrospective Studies

Many countries have seen an unprecedented rise of cases of coronavirus disease 2019 (COVID-19) associated mucormycosis (CAM). Cerebrovascular involvement in CAM has not been studied so far. We describe clinico-radiological manifestations of cerebrovascular complications observed in CAM.In this multicentric retrospective observational study from India, patients with CAM who developed cerebrovascular involvement were studied. Their demographics, risk factors, clinical manifestations, imaging, laboratory profile and outcomes were noted.Out of 49 subjects with cerebrovascular involvement, 71.4% were males while average age was 52.9 years. Ischemic stroke was commonest (91.8%) followed by intracranial haemorrhage (6.1%) and subarachnoid haemorrhage (2%). The incidence of cerebrovascular complications in CAM was found to be 11.8% in one center. Cerebrovascular symptoms appeared a median of 8.3 days from the onset of mucormycosis. Commonest presentation of mucormycosis was rhino-orbito-cerebral syndrome in 98%. Diabetes mellitus was present in 81.7%. Forty percent developed stroke despite being on antiplatelet agent and/or heparin. Amongst subjects with ischemic strokes, location of stroke was unilateral anterior circulation (62.2%); bilateral anterior circulation (17.8%); posterior circulation (11.1%) and combined anterior and posterior circulation (8.9%). Vascular imaging revealed intracranial occlusion in 62.1%; extracranial occlusion in 3.4% and normal vessels in 34.5%. Mortality was 51% during hospital stay.Cerebrovascular involvement was seen in 11.8% patients of CAM. Angio-invasive nature of the fungus, prothrombotic state created by COVID-19, and diabetes were important causative factors. Subjects with CAM should be screened for involvement of the brain as well as its vessel. Antiplatelet agents/heparin did not seem to provide complete protection from this type of stroke.